MegaMD Co

MegaMD Co Financial Leverage

The Financial Leverage (Equity Multiplier) of MegaMD Co (133750.KQ) as of Oct 21, 2026 is 1.25. In the previous year, Financial Leverage (Equity Multiplier) was 1.33 — a change of -5.61% (lower).

Financial Leverage

1.25

YoY

-5.61%

Last updated:

Financial Leverage (Equity Multiplier) of MegaMD Co is 2025 1.25 . Financial Leverage (Equity Multiplier) of MegaMD Co was 2024 1.33 . It decreases by -5.61% lower compared to the previous year.

The MegaMD Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2018
1.73 KRW
Jan 1, 2019
1.89 KRW
Jan 1, 2020
1.83 KRW
Jan 1, 2021
1.72 KRW
Jan 1, 2022
1.42 KRW
Jan 1, 2023
1.36 KRW
Jan 1, 2024
1.33 KRW
Jan 1, 2025
1.25 KRW
The MegaMD Co Financial Leverage history
YEARFinancial LeverageYoY
1.25-5.61%
1.33-2.38%
1.36-4.36%
1.42-17.28%
1.72-5.86%
1.83-3.23%
1.89+8.91%
1.73+9.08%
1.59+9.20%
1.46-1.28%
1.47-3.44%
1.53—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

MegaMD Co Stock analysis

What does MegaMD Co do? MegaMD Co., Ltd. generates revenue through test preparation courses for medical education eligibility tests (MEETs), dental education eligibility tests (DEETs), pharmacy education eligibility tests (PEETs), and legal education eligibility tests (LEETs), as well as online education services. The company also sells teaching materials related to these courses. Its primary customers are students preparing for these professional eligibility exams, with a focus on medical, dental, pharmacy, and legal fields. The firm targets individuals seeking certification in these specialized areas through its digital platform. MegaMD's product portfolio includes structured test preparation programs designed for specific professional exams, delivered via online platforms. The company's wholesale of teaching materials complements its course offerings, providing additional resources for students. Revenue streams are derived from course enrollments and material sales, serving a segment of learners dedicated to passing high-stakes professional qualification tests. The business model centers on delivering specialized educational content for four distinct professional fields: medical, dental, pharmacy, and legal. By offering tailored courses for MEETs, DEETs, PEETs, and LEETs, MegaMD addresses the needs of students in these sectors. The company's online delivery model ensures accessibility for a broad audience seeking certification in these regulated professions. MegaMD Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MegaMD Co stock

Financial Leverage (Equity Multiplier) of MegaMD Co is 1.25 in 2025.

Financial Leverage (Equity Multiplier) of MegaMD Co changed from 1.33 to 1.25, representing a -5.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) MegaMD Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s MegaMD Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — MegaMD Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — MegaMD Co